ACLX
Price
$78.23
Change
+$2.03 (+2.66%)
Updated
Oct 4 closing price
37 days until earnings call
ALLO
Price
$2.70
Change
+$0.09 (+3.45%)
Updated
Oct 4 closing price
26 days until earnings call
Ad is loading...

ACLX vs ALLO

Header iconACLX vs ALLO Comparison
Open Charts ACLX vs ALLOBanner chart's image
Arcellx
Price$78.23
Change+$2.03 (+2.66%)
Volume$408.39K
CapitalizationN/A
Allogene Therapeutics
Price$2.70
Change+$0.09 (+3.45%)
Volume$1.38M
CapitalizationN/A
View a ticker or compare two or three
ACLX vs ALLO Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACLX vs. ALLO commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a StrongSell and ALLO is a Hold.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (ACLX: $78.23 vs. ALLO: $2.70)
Brand notoriety: ACLX and ALLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 86% vs. ALLO: 72%
Market capitalization -- ACLX: $4.49B vs. ALLO: $608.51M
ACLX [@Biotechnology] is valued at $4.49B. ALLO’s [@Biotechnology] market capitalization is $608.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileALLO’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • ALLO’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while ALLO’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • ALLO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -5.47% price change this week, while ALLO (@Biotechnology) price change was -7.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 11, 2024.

ALLO is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.49B) has a higher market cap than ALLO($609M). ACLX YTD gains are higher at: 40.955 vs. ALLO (-15.888). ACLX has higher annual earnings (EBITDA): -46.86M vs. ALLO (-256.56M). ACLX has more cash in the bank: 517M vs. ALLO (445M). ACLX has less debt than ALLO: ACLX (74.3M) vs ALLO (87M). ACLX has higher revenues than ALLO: ACLX (145M) vs ALLO (65K).
ACLXALLOACLX / ALLO
Capitalization4.49B609M737%
EBITDA-46.86M-256.56M18%
Gain YTD40.955-15.888-258%
P/E RatioN/AN/A-
Revenue145M65K223,077%
Total Cash517M445M116%
Total Debt74.3M87M85%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXALLO
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 16 days ago
88%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIPTX16.170.05
+0.31%
Virtus KAR Global Quality Dividend I
AWTAX22.010.02
+0.09%
Virtus Duff & Phelps Water A
GCITX14.86N/A
N/A
Goldman Sachs Intl Eq Insghts Inv
NOIEX17.16N/A
N/A
Northern Income Equity
JNBCX10.12N/A
N/A
JPMorgan Income Builder C

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CRSP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+2.66%
CRSP - ACLX
49%
Loosely correlated
+1.05%
BEAM - ACLX
48%
Loosely correlated
+2.05%
NTLA - ACLX
47%
Loosely correlated
+1.93%
KYMR - ACLX
46%
Loosely correlated
-0.81%
ALLO - ACLX
46%
Loosely correlated
+3.45%
More

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with NTLA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+3.45%
NTLA - ALLO
60%
Loosely correlated
+1.93%
CRSP - ALLO
56%
Loosely correlated
+1.05%
EDIT - ALLO
56%
Loosely correlated
+5.63%
PRME - ALLO
55%
Loosely correlated
+2.93%
BEAM - ALLO
55%
Loosely correlated
+2.05%
More